Robert J. Holt - Concepedia

Author

Robert J. Holt

Horizon Therapeutics (United States)ORCID

Also Known As

H Demott, L. Puleo, R Holt, R. Holt, R. J. Holt, R.J. Holt, Robert Holt, Robert J Holt, Robert J. Holt

Publications

492

Citations

H-Index

Concepts

All Affiliations

Horizon Therapeutics (United States)University of Illinois Chicago Illinois Bone and Joint Institute Schlosspark-Klinik Icahn School of Medicine at Mount Sinai

About

Robert J. Holt is an author at Horizon Therapeutics (United States) specializing in drug safety, osteoarthritis, and rheumatology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	12
2	Microbiology	1	1	20
3	Pharmacology	1	1	12
4	Rheumatology	1	1	12
5	Drug Safety	1	1	12

Robert J. Holt

Publications

282

Citations

H-Index

Page 1

	Year	Citations
Efficacy and safety of diclofenac sodium 2% topical solution for osteoarthritis of the knee: a randomized, double-blind, vehicle-controlled, 4 week study Linda Wadsworth, Jeffrey D. Kent, Robert J. Holt Current Medical Research and Opinion	2015	42
Characteristics, Comorbidities, and Potential Consequences of Uncontrolled Gout: An Insurance-Claims Database Study Megan Francis‐Sedlak, Brian LaMoreaux, Lissa Padnick‐Silver, Rheumatology and Therapy	2020	25
Chemoprophylaxis of Recurrent Otitis Media Using Trimethoprim/Sulfamethoxazole John D. Gaskins, Robert J. Holt, Catherine U. Kyong, Drug Intelligence & Clinical Pharmacy	1982	23
Delayed-release prednisone improves fatigue and health-related quality of life: findings from the CAPRA-2 double-blind randomised study in rheumatoid arthritis Rieke Alten, Amy Grahn, Robert J. Holt, RMD Open	2015	21
Hypoprothrombinemia Associated with Moxalactam Treatment of a Septic Sternoclavicular Arthritis Due to <i>Citrobacter Diversus</i> Robert J. Holt, Martin Gorrochategui, Casilda Perez Drug Intelligence & Clinical Pharmacy Moxalactam TreatmentMicrobiologyHypoprothrombinemia Associated	1981	20
Long-term safety and efficacy of glycerol phenylbutyrate for the management of urea cycle disorder patients George A. Díaz, Andreas Schulze, Nicola Longo, Molecular Genetics and Metabolism	2019	18
Onset and durability of pain relief in knee osteoarthritis: Pooled results from two placebo trials of naproxen/esomeprazole combination and celecoxib Robert J. Holt, John G. Fort, Amy Grahn, The Physician and Sportsmedicine	2015	16
Stiffness Is the Cardinal Symptom of Inflammatory Musculoskeletal Diseases, Yet Still Variably Measured: Report from the OMERACT 2016 Stiffness Special Interest Group Serena Halls, Premarani Sinnathurai, Sarah Hewlett, The Journal of Rheumatology	2016	15
Bioequivalence of diclofenac sodium 2% and 1.5% topical solutions relative to oral diclofenac sodium in healthy volunteers Robert J. Holt, Tolu Taiwo, Jeffrey D. Kent Postgraduate Medicine	2015	13
Morning stiffness response with delayed-release prednisone after ineffective course of immediate-release prednisone Rieke Alten, Robert J. Holt, Amy Grahn, Scandinavian Journal of Rheumatology	2015	13

Page 1